Skip to content

A Study on Yastimadhu Triphala Vati in Simple Allergic Conjunctivitis

Efficacy Of Yashtimadhu Triphala Vati as a Prebiotic On Occular Microbiota in Simple Allergic Conjunctivitis: An Exploratory Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104039
Enrollment
30
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H101- Acute atopic conjunctivitis

Interventions

None listed

Sponsors

Dr. D. Y. Patil College of Ayurved and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting with minimum 3 of the total symptoms of Simple Allergic Conjunctivitis i.e Pricking Pain, Watering of eyes, and Foreign body sensation, Dryness, Presence of Papillae, Congestion of Conjunctiva will be selected Between the age group of 18 to 60 yrs. will be included in the study. Irrespective of daily routine and diet patients will be selected

Exclusion criteria

Exclusion criteria: Patients with any other ocular pathology like Bacterial conjunctivitis, corneal opacity, corneal ulcer, Malignancy, dacryocystitis.

Design outcomes

Primary

MeasureTime frame
Increase in total viable count of microorganisms in conjunctival swabs after treatment with Yashtimadhu Triphala Vati.Timepoint: 30 days with assessment on 0th day and 30th day

Secondary

MeasureTime frame
Reduction in signs and symptoms of allergic conjunctivitis such as: Pricking Pain, Watering of eyes, Foreign body sensation, Presence of Papillae, Congestion of Conjunctiva, Feeling of DrynessTimepoint: 30 days with assessment on 0th day and 30th day

Countries

India

Contacts

Public ContactDr Swarali Gangshettiwar

Dr. D. Y. Patil College of Ayurved and Research Centre Pune

pallavibhor78@gmail.com8983535924

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026